natgillin/translations-raw huggingface dataset:
As such a mode is highly unlikely and a pharmacological mode of action is most probable, this indicates that the group of products in question should not fall within the definition of medical devices.
Ker je tak način učinkovanja malo verjeten in je najverjetnejše farmakološko učinkovanje, navedena skupina izdelkov ne bi smela spadati v opredelitev medicinskih pripomočkov.
Results of a questionnaire circulated at the Medical Devices Expert Group in November 2014 showed that the majority of Member States, based on their scientific expertise, is of the view that this group of products should not fall within the definition of medical devices.
Rezultati vprašalnika, ki ga je strokovna skupina za medicinske pripomočke razdelila novembra 2014, kažejo, da je večina držav članic na podlagi znanstvenega strokovnega znanja mnenja, da navedena skupina izdelkov ne bi smela spadati v opredelitev medicinskih pripomočkov.
The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 7(1) of Directive 93/42/EEC,
Ukrepi iz tega sklepa so v skladu z mnenjem odbora, ustanovljenega s členom 7(1) Direktive 93/42/EGS –
The group of products whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium macrocarpon) extract, is to prevent or treat cystitis, does not fall within the definition of medical devices set out in point (a) of Article 1(2) of Directive 93/42/EEC.
Skupina izdelkov, katerih glavno predvideno učinkovanje, ki je odvisno od proantocianidinov v izvlečku brusnic (Vaccinium Macrocarpon), je preprečevanje ali zdravljenje cistitisa, ne spada v opredelitev medicinskih pripomočkov iz člena 1(2)(a) Direktive 93/42/EGS.
Done at Brussels, 8 August 2017.
V Bruslju, 8. avgusta 2017
OJ L 169, 12.7.1993, p. 1.
UL L 169, 12.7.1993, str. 1.
CHMP (Committee for Medicinal Products for Human Use) scientific opinion to DG Internal Market, Industry, Entrepreneurship and SMEs, Unit GROW D.4.
Znanstveno mnenje Odbora za zdravila za uporabo v humani medicini (CHMP) za GD za notranji trg, industrijo, podjetništvo ter mala in srednja podjetja (enota GROW D.4. za zdravstveno tehnologijo in kozmetiko) o glavnem načinu učinkovanja proantocianidinov, ki so namenjeni preprečevanju in zdravljenju okužb sečil, EMA/427414/2016, http://ec.europa.eu/growth/tools-databases/newsroom/cf/itemdetail.cfm?item_id=8684&lang=en.
Council Implementing Decision (CFSP) 2017/1458
Izvedbeni sklep Sveta (SZVP) 2017/1458
of 10 August 2017
z dne 10. avgusta 2017
Having regard to Council Decision (CFSP) 2015/1333 of 31 July 2015 concerning restrictive measures in view of the situation in Libya, and repealing Decision 2011/137/CFSP [1], and in particular Article 12(1) thereof,
ob upoštevanju Sklepa Sveta (SZVP) 2015/1333 z dne 31. julija 2015 o omejevalnih ukrepih zaradi razmer v Libiji in razveljavitvi Sklepa 2011/137/SZVP [1] ter zlasti člena 12(1) navedenega sklepa,
On 31 July 2015, the Council adopted Decision (CFSP) 2015/1333.
Svet je 31. julija 2015 sprejel Sklep (SZVP) 2015/1333.
On 2 August 2017, the United Nations Security Council Committee established pursuant to United Nations Security Council Resolution 1970 (2011) approved the addition of one vessel to the list of vessels subject to restrictive measures.
Odbor Varnostnega sveta Združenih narodov, ustanovljen na podlagi Resolucije Varnostnega sveta Združenih narodov 1970 (2011), je 2. avgusta 2017 odobril vključitev enega plovila na seznam plovil, za katera veljajo omejevalni ukrepi.
Annex V to Decision (CFSP) 2015/1333 should therefore be amended accordingly,
Prilogo V k Sklepu (SZVP) 2015/1333 bi bilo zato treba ustrezno spremeniti –
Annex V to Decision (CFSP) 2015/1333 is hereby amended as set out in the Annex to this Decision.
Priloga V k Sklepu (SZVP) 2015/1333 se spremeni v skladu s Prilogo k temu sklepu.
Done at Brussels, 10 August 2017.
V Bruslju, 10. avgusta 2017
OJ L 206, 1.8.2015, p. 34.
UL L 206, 1.8.2015, str. 34.
The vessel listed below shall be added to the list of vessels subject to restrictive measures set out in Annex V to Decision (CFSP) 2015/1333:
Na seznam plovil, za katere veljajo omejevalni ukrepi iz Priloge V k Sklepu (SZVP) 2015/1333, se doda naslednje plovilo:
Additional information
Dodatne informacije:
IMO: 8706349; Listed pursuant to paragraphs 10(a) and 10 (b) of Resolution 2146 (2014), as extended and modified by paragraph 2 of Resolution 2362 (2017) (prohibition to load, transport or discharge; prohibition to enter ports).
Številka IMO: 8706349; Na seznam uvrščena v skladu z odstavkom 10(a) in (b) Resolucije 2146 (2014), kakor je bila razširjena in spremenjena z odstavkom 2 Resolucije 2362 (2017) (prepoved natovarjanja, prevoza ali raztovarjanja; prepoved vstopa v pristanišča).
Pursuant to paragraph 11 of Resolution 2146, this designation is valid from 2 August to 2 November 2017, unless terminated earlier by the Committee pursuant to paragraph 12 of Resolution 2146.
V skladu z odstavkom 11 Resolucije 2146 ta uvrstitev na seznam velja od 2. avgusta do 2. novembra 2017, če je odbor prej ne razveljavi v skladu z odstavkom 12 Resolucije 2146.
Flag State: Saint Vincent and the Grenadines.
Država zastave: Sveti Vincenc in Grenadine.
As of 26 July 2017, the vessel was located in international waters approximately 50 nautical miles southeast of Cyprus.
Ladja se je od 26. julija 2017 nahajala v mednarodnih vodah približno 50 navtičnih milj jugovzhodno od Cipra.
Council Implementing Decision (CFSP) 2017/1459
Izvedbeni sklep Sveta (SZVP) 2017/1459
Having regard to Council Decision (CFSP) 2016/849 of 27 May 2016 concerning restrictive measures against the Democratic People's Republic of Korea and repealing Decision 2013/183/CFSP [1], and in particular Article 33(1) thereof,
ob upoštevanju Sklepa Sveta (SZVP) 2016/849 z dne 27. maja 2016 o omejevalnih ukrepih proti Demokratični ljudski republiki Koreji in razveljavitvi Sklepa 2013/183/SZVP [1] ter zlasti člena 33(1) Sklepa,
On 27 May 2016, the Council adopted Decision (CFSP) 2016/849.
Svet je 27. maja 2016 sprejel Sklep (SZVP) 2016/849.
On 5 August 2017, the United Nations Security Council adopted Resolution 2371 (2017), which added nine persons and four entities to the list of persons and entities subject to restrictive measures and amended the entries for two persons subject to restrictive measures.
Odbor Varnostnega sveta Združenih narodov je 5. avgusta 2017 z Resolucijo 2371 (2017) devet oseb in štiri subjekte uvrstil na seznam oseb in subjektov, za katere veljajo omejevalni ukrepi, ter posodobil podatke v zvezi z dvema osebama, za kateri veljajo omejevalni ukrepi.
Annex I to Decision (CFSP) 2016/849 is hereby amended as set out in the Annex to this Decision.
Priloga I k Sklepu (SZVP) 2016/849 se spremeni v skladu s Prilogo k temu sklepu.
OJ L 141, 28.5.2016, p. 79.
UL L 141, 28.5.2016, str. 79.
The persons and entities listed below are added to the list of persons and entities subject to restrictive measures set out in Annex I to Decision (CFSP) 2016/849.
Spodaj navedene osebe in subjekti se dodajo na seznam oseb in subjektov, za katere veljajo omejevalni ukrepi iz Priloge I k Sklepu (SZVP) 2016/849.
Passport No: 654410078
Št. potnega lista: 654410078
Gender: male
Spol: moški
Representative for Ilsim International Bank, which is affiliated with the DPRK military and has a close relationship with the Korea Kwangson Banking Corporation.
Predstavnik banke Ilsim International Bank, ki je povezana z vojsko DLRK in tesno povezana s Korea Kwangson Banking Corporation.
Ilsim International Bank has attempted to evade United Nations sanctions.
Banka Ilsim International Bank se je poskušala izogniti sankcijam Združenih narodov.
DOB: 8.11.1969
Datum rojstva: 8.11.1969
POB: Pyongyang, DPRK
Kraj rojstva: Pjongjang, DLRK
Passport No.: 745420176, expires on 19.10.2020
Št. potnega lista: 745420176, veljavnost poteče 19.10.2020
DOB: 12.3.1967
Datum rojstva: 12.3.1967
Jang Song Chol is a Korea Mining Development Corporation (KOMID) representative overseas.
Jang Song Chol je predstavnik družbe Korea Mining Development Corporation (KOMID) v tujini.
DOB: 14.7.1970
Datum rojstva: 14.7.1970
Passport No.: 563120368, issued on 22.3.2013; Passport expiration date: 22.3.2018
Št. potnega lista: 563120368, izdan 22.3.2013; datum poteka veljavnosti potnega lista: 22.3.2018
Chief of an overseas Tangun Trading Corporation branch, which is primarily responsible for the procurement of commodities and technologies to support the DPRK's defence research and development programs.
Vodja izpostave družbe Tangun Trading Corporation v tujini, katere glavna naloga je nabava blaga in tehnologij v podporo programom DLRK za raziskave in razvoj na področju obrambe.
DOB: 25.9.1984
Datum rojstva: 25.9.1984
Passport No: 654320502, expires on 16.9.2019
Št. potnega lista: 654320502, veljavnost poteče 16.9.2019
Deputy Representative for the Korea Kwangson Banking Corporation, which provides financial services in support to Tanchon Commercial Bank and Korea Hyoksin Trading, a subordinate entity of Korea Ryonbong General Corporation.
Namestnik predstavnika družbe Korea Kwangson Banking Corporation, ki zagotavlja finančne storitve za banko Tanchon Commercial Bank in družbo Korea Hyoksin Trading, podružnico družbe Korea Ryonbong General Corporation.
DOB: 13.2.1969
Datum rojstva: 13.2.1969
Passport No.: 472234895
Št. potnega lista: 472234895
Official for Korea Ryonbong General Corporation, which specializes in acquisition for the DPRK's defence industries and support for the DPRK's military-related overseas sales.
Funkcionar za podjetje Korea Ryonbong General Corporation, specializirano za nabavo blaga za obrambno industrijo DLRK in za podporo DLRK pri prodaji vojaškega blaga v tujini.
Its procurements also likely support the DPRK's chemical weapons program.
Njegove nabave prav tako verjetno podpirajo program kemičnega orožja v DLRK.
DOB: 25.3.1957
Datum rojstva: 25.3.1957
Representative for Korea United Development Bank.
Predstavnik banke Korea United Development Bank.
Passport No.: 654110043
Št. potnega lista: 654110043
Passport No.: 563120235
Št. potnega lista: 563120235
Official for Korea Ryonbong General Corporation, which specializes in acquisition for DPRK's defence industries and support to Pyongyang's military-related sales.
Funkcionar za podjetje Korea Ryonbong General Corporation, specializirano za nabavo blaga za obrambno industrijo DLRK in za podporo Pjongjangu pri prodaji vojaškega blaga.
FTB Building, Jungsong-dong, Central District, Pyongyang, DPRK
FTB Building, Jungsong-dong, Central District, Pjongjang, DLRK
Foreign Trade Bank is a state-owned bank and acts as the DPRK's primary foreign exchange bank and has provided key financial support to the Korea Kwangson Banking Corporation.
Banka Foreign Trade Bank je banka v državni lasti, ki deluje kot glavna devizna banka DLRK in je zagotovila ključno finančno podporo za družbo Korea Kwangson Banking Corporation.
Central District, Pyongyang, DPRK
Centralno okrožje, Pjongjang, DLRK
The Korean National Insurance Company is a DPRK financial and insurance company and is affiliated with Office 39.
Korean National Insurance Company je finančna in zavarovalniška družba DLRK, ki je povezana z Birojem 39.
Koryo Credit Development Bank operates in the financial services industry in the DPRK's economy.
Banka Koryo Credit Development Bank deluje v industriji finančnih storitev v okviru gospodarstva DLRK.
Mansudae Overseas Project Group of Companies engaged in, facilitated, or was responsible for the exportation of workers from the DPRK to other nations for construction-related activities including for statues and monuments to generate revenue for the Government of the DPRK or the Workers' Party of Korea.
Mansudae Overseas Project Group of Companies je opravila, omogočila ali bila odgovorna za izvoz delavcev iz DLRK v druge države v zvezi z dejavnostmi, povezanimi z gradbeništvom, vključno z izdelavo kipov in spomenikov, z namenom ustvarjanja dohodka za vlado DLRK ali Delavsko stranko Koreje.
The Mansudae Overseas Project Group of Companies has been reported to conduct business in countries in Africa and Southeast Asia including Algeria, Angola, Botswana, Benin, Cambodia, Chad, the Democratic Republic of the Congo, Equatorial Guinea, Malaysia, Mozambique, Madagascar, Namibia, Syria, Togo, and Zimbabwe.
V poročilih je navedeno, da je Mansudae Overseas Project Group of Companies poslovala v Afriki in Jugovzhodni Aziji, med drugim v Alžiriji, Angoli, Botsvani, Beninu, Kambodži, Čadu, Demokratični republiki Kongo, Ekvatorialni Gvineji, Maleziji, Mozambiku, Madagaskarju, Namibiji, Siriji, Togu in Zimbabveju.
The following entries for persons subject to restrictive measures set out in Annex I to Decision (CFSP) 2016/849 are replaced as set out below:
Naslednji vnosi za osebe, za katere veljajo omejevalni ukrepi iz Priloge I k Sklepu (SZVP) 2016/849, se nadomestijo z naslednjimi:
DOB: 15.4.1957 or 22.2.1958
Datum rojstva: 15.4.1957 ali 22.2.1958
Diplomatic Passport No.: 836110034 Date of expiration: 1.1.2020;
Diplomatski potni list št.: 836110034; datum poteka veljavnosti potnega lista: 1.1.2020;
Tanchon Commercial Bank Representative in Syria.
Predstavnik banke Tanchon Commercial Bank v Siriji.
DOB: 18.10.1976 or 25.8.1976;
Datum rojstva: 18.10.1976 ali 25.8.1976;
Passport No.: 4721202031; Date of expiration: 21.2.2017
Št. potnega lista: 4721202031; datum poteka veljavnosti potnega lista: 21.2.2017
Diplomatic Passport No.: 836110035 Date of expiration: 1.1.2020;
Diplomatski potni list št.: 836110035; datum poteka veljavnosti potnega lista: 1.1.2020;
Commission Implementing Decision (EU) 2017/1460
Izvedbeni sklep Komisije (EU) 2017/1460
(notified under document C(2017) 5471)
(notificirano pod dokumentarno številko C(2017) 5471)
Having regard to Council Directive 92/119/EEC of 17 December 1992 introducing general Community measures for the control of certain animal diseases and specific measures relating to swine vesicular disease [3], and in particular Article 14(2), Article 19(1)(a) and (3)(a), and Article 19(4) and (6) thereof,
ob upoštevanju Direktive Sveta 92/119/EGS z dne 17. decembra 1992 o splošnih ukrepih Skupnosti za nadzor nad določenimi živalskimi boleznimi in o posebnih ukrepih v primeru vezikularne bolezni prašičev [3] ter zlasti člena 14(2), člena 19(1)(a) in (3)(a) ter člena 19(4) in (6) Direktive,
Directive 92/119/EEC lays down general control measures to be applied in the event of an outbreak of certain animal diseases, including lumpy skin disease (LSD).
Direktiva 92/119/EGS določa splošne nadzorne ukrepe, ki se uporabijo v primeru izbruha določenih živalskih bolezni, vključno z vozličastim dermatitisom.
These control measures include the establishment of protection and surveillance zones around the infected holding, and they also provide for emergency vaccination in the case of an outbreak of LSD as a supplement to other control measures.
Ti nadzorni ukrepi vključujejo vzpostavitev okuženih in ogroženih območij okoli okuženega gospodarstva ter določajo cepljenje v izrednih razmerah v primeru izbruha vozličastega dermatitisa kot dopolnilo k drugim nadzornim ukrepom.
Commission Implementing Decision (EU) 2016/2008 [5] lays down animal health control measures in relation to the occurrence of LSD in certain Member States or parts thereof as listed in Annex I thereto, including the minimum requirements for vaccination programmes against LSD submitted by the Member States to the Commission for approval.
Izvedbeni sklep Komisije (EU) 2016/2008 [5] določa nadzorne ukrepe za zdravje živali v zvezi s pojavom vozličastega dermatitisa v nekaterih državah članicah ali njihovih delih, kot so navedeni v Prilogi I k navedenemu sklepu, vključno z minimalnimi zahtevami za programe cepljenja proti vozličastemu dermatitisu, ki so jih države članice predložile Komisiji v odobritev.
It defines ‘infected zones’ as the parts of the territory of a Member State listed in Part II of Annex I to that Implementing Decision which includes the areas where LSD was confirmed and any protection and surveillance zones established in accordance with Directive 92/119/EEC, and where vaccination against LSD may be implemented following the approval of vaccination programmes.
Okužena območja opredeljuje kot dele ozemlja države članice iz dela II Priloge I k navedenemu izvedbenemu sklepu, ki vključujejo območja, na katerih je bil potrjen vozličasti dermatitis, ter vsa okužena in ogrožena območja, vzpostavljena v skladu z Direktivo 92/119/EGS, in kjer se cepljenje proti vozličastemu dermatitisu lahko izvaja po odobritvi programov cepljenja.
It also defines ‘free zones with vaccination’ as the parts of the territory of a Member State listed in Part I of that Annex which include the areas outside the ‘infected zones’, where vaccination against LSD is implemented following the approval of vaccination programmes.
Prosta območja s cepljenjem pa opredeljuje kot dele ozemlja države članice iz dela I navedene priloge, ki vključujejo območja zunaj okuženih območij, kjer se cepljenje proti vozličastemu dermatitisu izvaja po odobritvi programov cepljenja.
Implementing Decision (EU) 2016/2008 provides for specific risk mitigation measures and trade restrictions in relation to live bovine animals and captive wild ruminants, their germinal products, and other products of those animals to be put in place in the ‘infected zones’ and ‘free zones with vaccination’, with a view to minimising any risk of the spread of LSD.
Izvedbeni sklep (EU) 2016/2008 določa posebne ukrepe za zmanjšanje tveganja in trgovinske omejitve v zvezi z živim govedom in divjimi prežvekovalci v ujetništvu, njihovim zarodnim materialom in drugimi proizvodi navedenih živali, ki se vzpostavijo na okuženih območjih in prostih območjih s cepljenjem, da se čim bolj zmanjša tveganje za širjenje vozličastega dermatitisa.
The Report of the European Food Safety Authority (EFSA) on LSD, approved on 27 March 2017 [6] (the EFSA Report of 2017), indicates that the results from the analysis of the available LSD epidemiological data in Europe until 2016 suggest that mass vaccination campaigns against LSD, where they were properly implemented, brought the disease under control by preventing the occurrence of new outbreaks.
V poročilu Evropske agencije za varnost hrane (v nadaljnjem besedilu: EFSA) o vozličastem dermatitisu, sprejetem 27. marca 2017 [6] (v nadaljnjem besedilu: poročilo EFSA iz leta 2017), je navedeno, da rezultati analize razpoložljivih epidemioloških podatkov o vozličastem dermatitisu v Evropi do leta 2016 kažejo, da je bilo z akcijami masovnega cepljenja proti vozličastemu dermatitisu, kjer so se ustrezno izvajale, mogoče obvladati bolezen s preprečevanjem pojava novih izbruhov.
These results corroborate the results of a previous urgent advice on lumpy skin disease, adopted by EFSA on 29 July 2016 [7] (the EFSA Advice of 2016), which concluded that mass vaccination is the most effective measure in controlling LSD, especially if protection of the vaccinated animals had already been developed before disease entry, namely, by preventive vaccination.
Ti rezultati potrjujejo rezultate predhodnega nujnega obvestila o vozličastem dermatitisu, ki ga je EFSA sprejela 29. julija 2016 [7] (v nadaljnjem besedilu: obvestilo EFSA iz leta 2016), da je masovno cepljenje najučinkovitejši ukrep za nadzor vozličastega dermatitisa, zlasti, če so se cepljene živali zaščitile že pred izbruhom bolezni, in sicer s preventivnim cepljenjem.
The effectiveness of the recent vaccination campaigns against LSD, as confirmed by the EFSA Advice of 2016 and the EFSA Report of 2017, suggests that properly vaccinated bovine animals may be moved from a ‘free zone with vaccination’ of a Member State to another Member State or third country or within the ‘free zone with vaccination’ or ‘infected zone’ of the same Member State using less restrictive rules.
Obvestilo EFSA iz leta 2016 in poročilo EFSA iz leta 2017 sta potrdila, da so bile nedavne akcije cepljenja proti vozličastemu dermatitisu tako učinkovite, da bi se ustrezno cepljeno govedo lahko premaknilo s prostega območja s cepljenjem, ki se nahaja v določeni državi članici, bodisi v drugo državo članico ali tretjo državo bodisi znotraj prostega območja s cepljenjem ali okuženega območja v isti državi članici, in sicer z uporabo manj omejevalnih pravil.
For the same reason less restrictive rules should apply for the movements of non- vaccinated calves born to vaccinated dams when they are moved within the same zone of the same Member State.
Iz istega razloga bi se morala manj omejevalna pravila uporabljati za premike necepljenih telet, ki so jih skotile cepljene matere, kadar se premaknejo znotraj istega območja v isti državi članici.
Equally, less restrictive rules should apply for the movements of non-vaccinated bovine animals and captive wild ruminants within the same ‘free zone with vaccination’ of the same Member State, when they are imported from Member States or third countries or zones thereof, not subject to restrictions related to LSD, since these types of movements can be considered as low risk for the spread of disease.
Manj omejevalna pravila bi se morala uporabljati tudi za premike necepljenega goveda in divjih prežvekovalcev v ujetništvu znotraj istega prostega območja s cepljenjem v isti državi članici, kadar se uvozijo iz držav članic ali tretjih držav ali njihovih območij, za katera ne veljajo omejitve v zvezi z vozličastim dermatitisom, saj se te vrste premikov lahko štejejo za premike z majhnim tveganjem za širjenje bolezni.
Croatia, Bulgaria and Greece, the three Member States currently implementing vaccination against LSD, and listed in Annex I to Implementing Decision (EU) 2016/2008, requested that that Implementing Decision be amended and in particular Articles 4, 5 and 6 thereof to accommodate less restrictive rules for the movements of vaccinated bovine animals and captive wild ruminants subject to revaccination as well as the movements of non-vaccinated calves born to vaccinated dams.
Tri države članice, in sicer Hrvaška, Bolgarija in Grčija, ki trenutno izvajajo cepljenje proti vozličastemu dermatitisu in so navedene v Prilogi I k Izvedbenemu sklepu (EU) 2016/2008, so zaprosile, da se navedeni izvedbeni sklep spremeni, zlasti pa členi 4, 5 in 6 Sklepa, in sicer, da se vanj vključijo manj omejevalna pravila za premike cepljenega goveda in divjih prežvekovalcev v ujetništvu, če se ponovno cepijo, ter za premike necepljenih telet, ki so jih skotile cepljene matere.
In addition Croatia requested less restrictive rules for the movements of non-vaccinated bovine animals and captive wild ruminants originating from Member States or third countries or zones thereof not subject to restrictions due to confirmation of the presence of LSD or vaccination against it.
Poleg tega je Hrvaška zaprosila za manj omejevalna pravila v zvezi s premiki necepljenega goveda in divjih prežvekovalcev v ujetništvu, ki izvirajo iz držav članic ali tretjih držav ali njihovih območij, za katera ne veljajo omejitve zaradi potrjene prisotnosti vozličastega dermatitisa ali cepljenja proti njemu.
The risk of spread of LSD due to the movement of live bovine animals and captive wild ruminants vaccinated against LSD, is higher when they receive a vaccination for the first time compared to the same risk when they receive a revaccination while still immune due to previous vaccination.
Tveganje za širjenje vozličastega dermatitisa zaradi premika živega goveda in divjih prežvekovalcev v ujetništvu, cepljenih proti vozličastemu dermatitisu, je večje, kadar so cepljeni prvič, v primerjavi z istim tveganjem, kadar so ponovno cepljeni in so zaradi predhodnega cepljenja še vedno imuni.
Accordingly the risk of spread of LSD is higher when the holding of origin of these animals is vaccinated for the first time compared to the same risk when the holding is revaccinated in the period when the animals present are still immune due to previous vaccination.
V skladu s tem je tveganje za širjenje vozličastega dermatitisa večje, kadar na gospodarstvu izvora teh živali cepljenje poteka prvič, v primerjavi z istim tveganjem, kadar na gospodarstvu poteka ponovno cepljenje v obdobju, ko so prisotne živali zaradi predhodnega cepljenja še vedno imune.